Akoustis™ Co-Chairman, Jerry Neal, Leads $1.61 Million

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Akoustis™ Co-Chairman, Jerry Neal, Leads $1.61 Million Financing Round

Charlotte, N.C., Nov. 28, 2016 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (OTCQB: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented BulkONE™ bulk acoustic wave (BAW) high band RF filters for mobile wireless, announced today a closing of a private placement offering in which it sold 322,000 shares of common stock to accredited investors at a fixed purchase price of $5.00 per share, for aggregate gross proceeds of $1,610,000. The round was led by Akoustis Co-Chairman, Jerry Neal as well as Steven Miller, the founder and former Chairman and CEO of Sawtek Inc., which was sold to TriQuint Semiconductor in 2001. Akoustis management also participated, including CEO, Jeff Shealy, recently appointed VP Engineering, Rohan Houlden, and VP Operations, Mark Boomgarden. Akoustis CEO, Jeff Shealy, commented, “I would like to thank our co-Chairman Jerry Neal as well as welcome Steven Miller as a new investor in Akoustis. I believe the investment by Akoustis insiders demonstrates the confidence within the Company regarding our patented BAW RF technology.” The Company intends to use the proceeds from the offering principally to support operations and the continued development and qualification of its premium high-band BAW RF filters utilizing its patented single-crystal piezoelectric materials. The offer and sale of the foregoing securities was made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the Securities Act), or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. As part of the transaction, the Company has agreed to file a registration statement with the Securities and Exchange Commission for purposes of registering the resale by the investors of the shares of common stock purchased by such investors. This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state. Any offering of the securities under the resale registration statement will only be by means of a prospectus. About Akoustis Akoustis™ (http://www.akoustis.com) is a high-tech RF filter solutions company that manufactures its unique, patent-pending BulkONE™ technology to produce single crystal bulk acoustic wave (BAW) RF filters for the mobile-wireless industry, which facilitate signal acquisition and accelerate band performance between the antenna and the back end of mobile devices. Its BulkONE™ technology will service the fast growing multi-billion dollar market of device OEMs, network providers, and consumers to diminish front end phone heat, battery drain and signal loss -- all considered to be directly related to current RF polycrystalline filter technologies’ limitations. Akoustis’ capital-efficient business model leverages third party investments and existing manufacturing infrastructure in the semiconductor industry. Akoustis™ is located in the Piedmont technology corridor between Charlotte and Raleigh, North Carolina. Forward-Looking Statements Statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management’s current expectations and assumptions and are subject to risks and uncertainties. In some cases, you can identify forward-looking statements by terminology including “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” “will,” “would” or the negative of these terms or other comparable terminology. Factors that could cause actual results to differ materially from those currently anticipated include, without limitation, • risks relating to the results of our research and development activities, including uncertainties relating to semiconductor process manufacturing; • the early stage of our BulkONE™ technology presently under development; • our need for substantial additional funds in order to continue our operations and the uncertainty of whether we will be able to obtain the funding we need; • our ability to retain or hire key scientific, engineering or management personnel; • our ability to protect our intellectual property rights that are valuable to our business, including patent and other intellectual property rights; • our dependence on third-party manufacturers, suppliers, research organizations, testing laboratories and other potential collaborators; • our ability to successfully market and sell our technologies; • the size and growth of the potential markets for any of our technologies, and the rate and degree of market acceptance of any of our technologies; • competition in our industry; and • regulatory developments in the U.S. and foreign countries. In light of these risks, uncertainties and assumptions, the future events and circumstances discussed in the forward-looking statements in this press release may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements included in this presentation speak only as of the date hereof, and, except as required by law, we undertake no obligation to update publicly or privately any forward-looking statements for any reason after the date of this presentation to conform these statements to actual results or to changes in our expectations. The materials do not constitute an offer to sell, or the solicitation of any offer to buy, any securities of Akoustis, or any other entity whatsoever. Any representation to the contrary by any party should be ignored.

Akoustis Contact Information: COMPANY: Dave Aichele Akoustis, Inc. VP of Business Development Main: 704-997-5735, ext. 106 Email: daichele@akoustis.com INVESTORS: The Del Mar Consulting Group, Inc. Robert B. Prag, President 858-794-9500 bprag@delmarconsulting.com or Integra Consulting Group LLC Jeremy Roe, Managing Partner 925-262-8305 jeremy@integracg.net

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Updated Category News Views 100

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Continue Reading
Hollywood Vampires' Limited Art Sparks Las Vegas Buzz

Updated Category News Views 117

A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...

Continue Reading
?atwogang Leads Tiltify's Impact Creator Class of 2026

Updated Category News Views 60

Charity Meets Creativity: A New Era Unveiled Who would have thought? Charitable fundraising is no longer just about writing checks. It's about creativity, community, and leveraging tech to drive change. Enter Tiltify's Creator Impact Class of 2026—proof that we're living in a brave new world where internet creators are the kings and queens of giving. ?atwogang Takes...

Continue Reading
Alchemy's Texas Move: Strategic Growth or Gamble?

Updated Category News Views 80

Making a Splash in Texas IT Services Alchemy Technology Group's acquisition of Freeit Data Solutions isn't just another drop in the tech pond; it's a cannonball aimed at shaking up the IT and cybersecurity scenes in Texas. By bringing Freeit's impressive 16-year track record under its wing, Alchemy is flexing its muscles in a region already bustling with IT infrastructure...

Continue Reading
Group 1 Automotive Q3 2026: Profits Soar, Revenues Dip

Updated Category News Views 34

Profits Up, Revenues Down Here's a tale for the books—Group 1 Automotive reports their third quarter results of 2026 and it's a bit like swapping a thunderstorm for a hurricane. Net income from continuing operations stomped on last year's figures, clocking in at a hefty $102.9 million compared to a skimpy $13.1 million. But don't let that fool you, their total revenues...

Continue Reading
Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 49

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 66

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Palmdale Propane Expands with Affordable Gas Buy

Updated Category News Views 50

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Continue Reading
Northeast Indiana Bancorp Shows Solid Third Quarter Gains

Updated Category News Views 47

Holding Steady in a Shaky Market In a market often rocked by turbulence, it seems Northeast Indiana Bancorp, Inc. has found a decent footing to stand on. Announcing their third-quarter results for 2026, they’ve posted net income of $1.991 million, showcasing a neat jump from the $1.793 million in the same period last year. Not bad at all for the parent company of First...

Continue Reading

Top 5 Most Recently Viewed Articles

Boosty Labs Elevates Leadership to Fuel 2025 Vision

Updated Category News Views 170

Boosty Labs Moves Forward with Strategic Leadership Changes Boosty Labs, a prominent name in Blockchain, Bitcoin, and Web3 development, is taking a substantial leap forward. As the company prepares for significant growth, the leadership team has undergone key changes aimed at driving operational excellence and innovation. New Roles for Vitalii Yatskiv and Denys Doronin In...

Continue Reading
Sinclair Inc. Elevates Leadership With Key Promotions

Updated Category News Views 236

Sinclair Inc. Elevates Leadership With Key Promotions BALTIMORE - Sinclair Inc. (NASDAQ: SBGI), a significant force in the media landscape recognized for its local news and sports coverage, with a market capitalization of $963 million, has recently elevated several key executives within its organizational structure and various subsidiaries. These strategic executive...

Continue Reading
Nasus Pharma's IPO: Paving the Way for Innovative Treatments

Updated Category News Views 172

Nasus Pharma Completes Initial Public Offering Nasus Pharma Ltd. (NYSE: NSRX) recently celebrated the successful conclusion of its initial public offering (IPO), marking a significant milestone for the company. This clinical-stage pharmaceutical firm, based in Israel, specializes in developing innovative intranasal products designed for treating emergency medical...

Continue Reading
Discover the Compact Keurig® K-Mini Mate™ Brewer Today

Updated Category News Views 105

Introducing the Keurig® K-Mini Mate™ Brewer The world of coffee brewing has evolved with the introduction of the Keurig® K-Mini Mate™ Brewer. This remarkable machine, available exclusively at Target, marks a significant leap in convenience and taste. Notably small at just 4 inches wide, this brewer is perfect for anyone who values space without wanting to sacrifice...

Continue Reading
Explore Telix Pharmaceuticals' Latest Innovations in Urology

Updated Category News Views 179

Join Telix Pharmaceuticals for a Pioneering Webinar Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX) is excited to extend an invitation to investors for a comprehensive webinar centered on the company’s leading-edge developments in urology. This event will highlight innovative approaches to treating prostate and kidney cancers, showcasing the remarkable potential...

Continue Reading